ATLASSutro Biopharma (STRO) earnings date: Nov 5, 2026
Sutro Biopharma (STRO) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026. Analysts expect EPS of -$1.88.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on STRO
| Last price | $9.13 (+0.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.0% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Sutro Biopharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Sutro Biopharma reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Sutro Biopharma. You can switch it off at any time.
Alert me before STRO reportsFree to start. Creating an account takes under a minute.
STRO earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.88 |
| Last report | Aug 12, 2026 · In line |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | +13.8% |
| Average move around a report | ±12.4% (last 5) |
| Sector | Healthcare · Biotechnology |
Sutro Biopharma earnings history: last 5 reports
Sutro Biopharma last reported on Aug 12, 2026: EPS of -$2.31 against an estimate of -$2.29 (-0.9% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$2.29 | -$2.31 | -0.9% | In line | -14.9% |
| Jun 29, 2026 | -$0.11 | -$0.02 | +81.8% | Beat | +8.8% |
| May 14, 2026 | -$3.21 | -$2.94 | +8.4% | Beat | -1.6% |
| Mar 23, 2026 | -$4.43 | -$4.88 | -10.2% | Miss | +14.0% |
| Jan 14, 2026 | $0.20 | $0.18 | -10.0% | Miss | +23.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for STRO
See the fair value, the probability range and the earnings history of Sutro Biopharma on its ATLAS page.
Sutro Biopharma (STRO) stock analysisPlans from €3.99 a month.
Sutro Biopharma earnings: frequently asked questions
When does Sutro Biopharma (STRO) report earnings?
Sutro Biopharma is scheduled to report on Thursday, November 5, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for STRO?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.88 per share (USD). Estimates can change before the report.
How often does STRO beat earnings estimates?
Of its last 5 reports with a recorded result, Sutro Biopharma beat the EPS estimate 2 times; the average surprise was +13.8%. Past results do not predict the next one.
How much does STRO move around earnings?
Over its last 5 reports the stock moved an average of 12.4% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Sutro Biopharma beat earnings estimates last quarter?
Sutro Biopharma last reported on Aug 12, 2026: EPS of -$2.31 against an estimate of -$2.29 (-0.9% surprise), in line with the estimate.
How much does STRO usually move in a day?
On a normal trading day the ATLAS model puts STRO’s one-day range at about ±5.0%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer